吲哚-6-甲醇 | 1075-26-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 吲哚-6-甲醇
• 中文别名: 6-羟甲基吲哚
• 英文名称: (1H-indol-6-yl)methanol
• 英文别名: 6-(hydroxymethyl)indole；1H-indol-6-ylmethanol
• CAS: 1075-26-9
• 化学式: C₉H₉NO
• mdl: MFCD02179595
• 分子量: 147.177
• InChiKey: WRMZOPANDOHWJU-UHFFFAOYSA-N

物化性质

• 熔点：
  45-50°C
• 沸点：
  360.6±17.0 °C(Predicted)
• 密度：
  1.272±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  36
• 氢给体数：
  2
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R37/38,R41
• 海关编码：
  2933990090
• 危险类别：
  IRRITANT
• 安全说明：
  S24/25
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Indole-6-methanol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H318: Causes serious eye damage
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: Indole-6-methanol
CAS number: 1075-26-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C9H9NO
Molecular weight: 147.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  吲哚-6-甲醇 在 钯 作用下， 以 乙醇 、 溶剂黄146 为溶剂， 反应 20.0h， 生成 6-甲基吲哚
  参考文献：
  名称：

  Serotonerbic tetrahydropyridoindoles

  摘要：

  本发明提供了新颖的、可选择取代的四氢吡啶并吲哚，它们是治疗中枢神经系统疾病的有用的血清素药物。

  公开号：

  US05563147A1
• 作为产物：
  描述：

  4-甲基-3-硝基苯甲醛 在 三氯化钛 作用下， 以 四氢呋喃 、 吡啶 、 N,N-二甲基甲酰胺 为溶剂， 反应 13.83h， 生成 吲哚-6-甲醇
  参考文献：
  名称：

  Somei, Masanori, Chemical and pharmaceutical bulletin, 1986, vol. 34, # 10, p. 4109 - 4115

  摘要：

  DOI：

文献信息

• Aliphatic carboxamides
  申请人：ICI Americas Inc.

  公开号：US04894386A1

  公开（公告）日：1990-01-16

  This invention provides a series of novel heterocyclic aliphatic carboxamides of formula I in which the group >Z--Y--X< is selected from >C.dbd.CH--N<, >N--CH.dbd.C<, >C.dbd.N--N< and >N--N.dbd.C< and the other radicals have the meanings defined in the following specification. The compounds of formula I are leukotriene antagonists. The invention also provides pharmaceutically acceptable salts of the formula I compounds; pharmaceutical compositions containing the formula I compound, or their salts, for use in the treatment of, for example, allergic or inflammatory diseases, or endotoxic or traumatic shock conditions; and processes for the manufacture of the formula I compounds, as well as intermediates for use in such manufacture.

  这项发明提供了一系列新颖的杂环脂肪族羧酰胺，其化学式为I，在该化合物中，基团>Z--Y--X<选择自>C.dbd.CH--N<，>N--CH.dbd.C<，>C.dbd.N--N<和>N--N.dbd.C<，其他基团的含义在以下说明中定义。化合物的化学式I是白三烯拮抗剂。该发明还提供了化学式I化合物的药学上可接受的盐；含有化学式I化合物或其盐的药物组合物，用于治疗过敏性或炎症性疾病，或内毒素性或创伤性休克等疾病；以及用于制造化学式I化合物的工艺，以及用于该制造的中间体。
• Polypyridyl iridium(III) based catalysts for highly chemoselective hydrogenation of aldehydes
  作者：Mallesh Pandrala、Angel Resendez、Sanjay V. Malhotra

  DOI：10.1016/j.jcat.2019.08.025

  日期：2019.10

  polypyridyl iridium(III) catalysts, [Ir(tpy)(L)Cl](PF6)2 where tpy = 2,2′:6′,2′'-Terpyridine, L = phen (1,10-Phenanthroline), Me2phen (4,7-Dimethyl-1,10-phenanthroline), Me4phen (3,4,7,8-Tetramethyl-1,10-phenanthroline), Me2bpy (4,4′-Dimethyl-2–2′-dipyridyl)} for the chemoselective reduction of aldehydes to alcohols in aqueous ethanol and sodium formate as the hydride source. The reaction can be carried

  使用HCOOR（R = H，Na，NH 4）作为氢源的铱催化的羰基化合物的转移加氢（TH）是关键过程，因为它提供了清洁的过程并且易于执行。但是，现有的高效铱催化剂只能在较窄的pH值下工作。因此，不适用于各种各样的基板。因此，开发在宽pH范围内工作的新型催化剂是必不可少的，因为它可以获得更广阔的应用范围。在这里我们报告了高效的聚吡啶基铱（III）催化剂[Ir（tpy）（L）Cl]（PF 6）2 其中tpy = 2,2'：6'，2''-三联吡啶，L = phen（1 ，10-菲咯啉），Me 2 phen（4,7-二甲基-1,10-菲咯啉），Me 4苯（3,4,7,8-四甲基-1,10-菲咯啉），Me 2bpy（4,4'-Dimethyl-2–2'-dipyridylyl）}用于将乙醛在乙醇水溶液和甲酸钠作为氢化物来源中化学选择性还原为醇。该反应可在pH范围6至11的宽pH范围内有效地进行。这
• [EN] VIRAL REPLICATION INHIBITORS<br/>[FR] INHIBITEURS DE REPLICATION VIRALE
  申请人：UNIV LEUVEN KATH

  公开号：WO2013045516A1

  公开（公告）日：2013-04-04

  The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.

  本发明涉及一系列新化合物，通过使用这些新化合物来预防或治疗动物的病毒感染的方法，以及将这些新化合物用作药物，更好地用于治疗或预防病毒感染，特别是感染RNA病毒，更特别是感染属于黄病毒科的病毒，更特别是感染登革病毒。本发明还涉及这些新化合物的药物组合或混合制剂，用作药物的组合或制剂，更好地用于预防或治疗病毒感染。该发明还涉及这些化合物的制备方法。
• Agents and methods for the treatment of proliferative diseases
  申请人：——

  公开号：US20030229026A1

  公开（公告）日：2003-12-11

  The present invention provides selective kinase inhibitors of formula (I). 1

  这项发明提供了式（I）的选择性激酶抑制剂。
• [EN] HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY<br/>[FR] COMPOSES HETEROCYCLIQUES, PROCEDES DE PRODUCTION DE CEUX-CI ET UTILISATION DE CEUX-CI DANS UN TRAITEMENT
  申请人：AFFINIUM PHARM INC

  公开号：WO2004052890A1

  公开（公告）日：2004-06-24

  In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.

  在某种程度上，本发明涉及公式（I）的抗菌化合物，其中A是一个双环杂芳基环或三环环，R2是一个杂环残基；L是一个键，或者L是烷基，烯基或环烷基。